VivoSim Labs, Inc. Stock: price and insider trades · United States

This page follows insider dealings at VivoSim Labs, Inc. as filed with SEC (Form 4), a company from the Health Care sector based in San Diego, United States. The group dates from 2007. 6 insiders have disclosed 7 filings since 24 October 2025.

Purchases and sales both appear in the filings: 1 purchase (1 insider, €2,418) and 1 sale (1 insider, €6,285). Sales outweigh purchases by €3,866. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a sale of €6,285 by Gobel David, published on 19 November 2025. The buyers include 1 senior executive.

Compared with its exchange (3,169 companies, median 24 filings), a count of 7 filings is below the norm. Our records for VivoSim Labs, Inc. go back to 2012, with 9 purchases and 31 sales on the open market in total. On the fundamentals side, the SEC filing (10-K) for the period ending 31 March 2026 lists revenue at 131,000 USD and net income at -13.8 m USD.

The most recent open-market purchase was published on 1 September 2026, 53 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.